Digital whole‐slide imaging of changes in amyloid after peripheral blood stem cell transplantation in patients with amyloid light‐chain amyloidosis
- 17 July 2024
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 74 (9) , 508-519
Abstract
Peripheral blood stem cell transplantation (PBSCT) has made amyloid light‐chain (AL) amyloidosis treatable. After PBSCT, hematological complete remission (HCR) can be achieved, leading to improved renal prognosis. The purpose of this study was to evaluate whether whole slide imaging of biopsy samples shows a post‐treatment reduction in amyloid deposits in patients with AL amyloidosis. Patients were divided into three groups: Group A (n = 8), not eligible for PBSCT and treated with other therapies; Group B (n = 11), treated with PBSCT and achieved HCR; and Group C (n = 5), treated with PBSCT but did not achieve HCR. Clinical findings and amyloid deposition in glomeruli, interstitium, and blood vessels were compared before and after treatment using digital whole‐slide imaging. Proteinuria and hypoalbuminemia improved more in Group B than in the other groups, and in Group B, amyloid deposition improved more in the glomeruli than in the interstitium and blood vessels. The long‐term renal and survival prognosis was better in Group B than in the other groups. PBSCT can be expected to improve long‐term clinical and renal histological prognosis in patients with AL amyloidosis who achieve HCR. Amyloid disappearance from renal tissue may take a long time even after clinical HCR.Keywords
Funding Information
- Okinaka Memorial Institute for Medical Research (2023‐9)
This publication has 25 references indexed in Scilit:
- Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume MappingJACC: Cardiovascular Imaging, 2023
- Renal Function in Aged C57BL/6J Mice Is Impaired by Deposition of Age-Related Apolipoprotein A-II Amyloid Independent of Kidney AgingThe American Journal of Pathology, 2023
- Using digital whole-slide images to evaluate renal amyloid deposition and its association with clinical features and outcomes of AL amyloidosisJournal Of Nephrology, 2021
- Kidney biopsy guidebook 2020 in JapanClinical and Experimental Nephrology, 2021
- Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosisCEN Case Reports, 2019
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- How to treat patients with systemic amyloid light chain amyloidosis? Comparison of high-dose melphalan, low-dose chemotherapy and no chemotherapy in patients with or without cardiac amyloidosisClinical and Experimental Nephrology, 2011
- Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantationClinical and Experimental Nephrology, 2009
- Successful use of a humanized anti–interleukin‐6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritisArthritis & Rheumatism, 2006
- Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosisPathology International, 2001